Another systematic meta-analysis of 17 studies further confirmed that MDK showed better performance in diagnosing early-stage HCC than AFP: AUROC, 0.89 vs. 0.52, sensitivity, 84% vs. 44%, specificity, 82% vs. 85% (Lu et al. 2020) (Table 1). The gene discussed is AFP; the disease is hepatocellular carcinoma.